Digging into the science–and promise–of long-acting injectable PrEP
From lenacapavir offering 100% protection against HIV among cis women, to the potential for long-acting PrEP to end the HIV epidemic, Liz Highleyman offers a thorough overview of the current state of injectable PrEP.
In August, Overdose Awareness Month, we commemorate loved ones lost to fatal overdose and advocate for compassionate, evidence-based solutions to end the overdose crisis.
Yes, doxycycline prevents STIs in cisgender women too
For the first time, research demonstrates that doxycycline taken daily reduces STI incidence by 67% in cisgender women. Gus Cairns explains the science, and shares why previous studies may have failed.
Being an ally is about more than just love – it's about education, fierce advocacy, and using your resources and power shatter stereotypes and create change.
HIV criminalization and “aggravated prostitution”–what’s the harm?
With expertise from the Center for HIV Law & Policy, Charles shares the negative impact caused by HIV criminalization laws, when “aggravated prostitution” charges enhance the sentences of people living with HIV.
Relying on his own experience, Charles Orgbon III explores how we can begin to dismantle harmful patterns of racial fetishization and build a culture of understanding and respect.
Why are we still here when so many of our friends and lovers died?
For HIV Long-Term Survivor Awareness Day, Hank Trout shares the stories of long-term survivors--and how they're come to terms with surviving after so much loss.
